Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 1996

View Archived Issues

Takeda discloses new agents for neurodegenerative disorders

New antioxidant from Shiseido shows CNS activity

New cardiovascular agents claimed by Hoechst

New taxane derivatives from Rhone-Poulenc Rorer

New NO inhibitors disclosed by Fujisawa

Japanese researchers describe orally active antihypertensive agents

Chugai discloses erythromycins for gastrointestinal disorders

Company Profile: Abgenix

Company profile: BioNumerik

Company profile: Corixa

Company profile: Forbes Medi-Tech

Clinical results reported for rhIGF-I in ALS patients

Ebselen on track for NDA filing in Japan

Agreement reached for atorvastatin development in Japan

XOMA receives U.S. patents covering BPI-related products

Water-soluble fiber introduced in first market for high cholesterol

Initial human safety studies completed for CoCensys' stroke drug

Children's Hospital of Philadelphia offers antimicrobial peptides for licensing

Potential drug screening invention available for licensing

Taiho antirheumatic agent possesses novel mechanism of action

Fujisawa antidementia agent in clinical stage

First approval for Aricept

New biochemical marker for Alzheimer's disease identified

FDA clears treatment for bulimia

FDA approves Amphotec

Trinity Biotech obtains license option for hepatitis A antigens

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...